These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8877030)

  • 1. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus.
    Lam KS; Wat MS; Choi KL; Ip TP; Pang RW; Kumana CR
    Br J Clin Pharmacol; 1996 Sep; 42(3):379-85. PubMed ID: 8877030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
    Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term treatment of central diabetes insipidus with oral DDAVP].
    Carraro A; Fano M; Cuttica M; Bernareggi V; Giusti M; Giordano G
    Minerva Endocrinol; 1992; 17(4):189-93. PubMed ID: 1308923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-D-arginine vasopressin. 1. Studies in adults and children.
    Williams TD; Dunger DB; Lyon CC; Lewis RJ; Taylor F; Lightman SL
    J Clin Endocrinol Metab; 1986 Jul; 63(1):129-32. PubMed ID: 3711257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
    Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
    Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central diabetes insipidus in children. V. Oral treatment with a vasopressin hormone analogue (DDAVP).
    Fjellestad A; Czernichow P
    Acta Paediatr Scand; 1986 Jul; 75(4):605-10. PubMed ID: 3529809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral DDAVP is a good alternative therapy for patients with central diabetes insipidus: experience of five-year treatment.
    Fukuda I; Hizuka N; Takano K
    Endocr J; 2003 Aug; 50(4):437-43. PubMed ID: 14599118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Water-balance hormones during long-term follow-up of oral dDAVP treatment in diabetes insipidus.
    Fjellestad-Paulsen A; Laborde K; Kindermans C; Czernichow P
    Acta Paediatr; 1993 Sep; 82(9):752-7. PubMed ID: 8241672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
    Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral antidiuretic therapy: studies in the diabetes insipidus rat.
    Kinter LB; Beeuwkes R
    Am J Physiol; 1982 Nov; 243(5):R491-9. PubMed ID: 7137378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of 1-deamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers.
    Fjellestad-Paulsen A; Höglund P; Lundin S; Paulsen O
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):177-82. PubMed ID: 8435898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Deamino-8-D-arginine vasopressin and urine cyclic adenosine monophosphate excretion in diabetes insipidus.
    Blackett PR; Seely JR; Altmiller DH; Males JL
    Clin Pharmacol Ther; 1981 Jun; 29(6):793-7. PubMed ID: 6262005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiuretic and PGE2 responses to AVP and dDAVP in subjects with central and nephrogenic diabetes insipidus.
    Moses AM; Scheinman SJ; Schroeder ET
    Am J Physiol; 1985 Mar; 248(3 Pt 2):F354-9. PubMed ID: 3856399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral desmopressin treatment of central diabetes insipidus in children.
    Boulgourdjian EM; Martínez AS; Ropelato MG; Heinrich JJ; Bergadá C
    Acta Paediatr; 1997 Nov; 86(11):1261-2. PubMed ID: 9401525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus.
    Laczi F; Mezei G; Julesz J; Lázló FA
    Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):63-8. PubMed ID: 7216552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man.
    Radó JP; Marosi J; Fischer J; Takó J; Kiss N
    Endokrinologie; 1975 Nov; 66(2):184-95. PubMed ID: 1236681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study.
    Arima H; Oiso Y; Juul KV; Nørgaard JP
    Endocr J; 2013; 60(9):1085-94. PubMed ID: 23811987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin.
    Hammer M; Vilhardt H
    J Pharmacol Exp Ther; 1985 Sep; 234(3):754-60. PubMed ID: 4032289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDAVP in the treatment of central diabetes insipidus.
    Robinson AG
    N Engl J Med; 1976 Mar; 294(10):507-11. PubMed ID: 1250255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L; Mezei G; László FA
    Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.